Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Randomized, controlled crossover study of IVIg for demyelinating polyneuropathy and diabetes.

Breiner A, Barnett Tapia C, Lovblom LE, Perkins BA, Katzberg HD, Bril V.

Neurol Neuroimmunol Neuroinflamm. 2019 Jul 10;6(5). pii: e586. doi: 10.1212/NXI.0000000000000586. Print 2019 Sep.

2.

Validation of a simple disease-specific, quality-of-life measure for diabetic polyneuropathy: CAPPRI.

Gwathmey KG, Sadjadi R, Horton WB, Conaway MR, Barnett-Tapia C, Bril V, Russell JW, Shaibani A, Mauermann ML, Hehir MK, Kolb N, Guptill J, Hobson-Webb L, Gable K, Raja S, Silvestri N, Wolfe GI, Smith AG, Malik R, Traub R, Joshi A, Elliott MP, Jones S, Burns TM.

Neurology. 2018 Jun 5;90(23):e2034-e2041. doi: 10.1212/WNL.0000000000005643. Epub 2018 May 4.

3.

IVIG and PLEX in the treatment of myasthenia gravis.

Bril V, Barnett-Tapia C, Barth D, Katzberg HD.

Ann N Y Acad Sci. 2012 Dec;1275:1-6. doi: 10.1111/j.1749-6632.2012.06767.x.

PMID:
23278570

Supplemental Content

Loading ...
Support Center